SK’s pneumococcal conjugate vaccine to be discussed at Central Pharmacists Deliberation Committee
The government will hold the Central Pharmacists Deliberation Committee over the conditional approval and clinical trials of the 13-valent pneumococcal conjugate vaccine that are being developed by SK Chemicals.
The target product of the committee is ‘Sky Pneumo Prefilled Syringe,’ a vaccine th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
